Live Chat Software

Facing The Ethical Minefield: Early Access Programmes

Facing The Ethical Minefield: Early Access Programmes
There are numerous ethical landmines for pharmaceutical
companies to consider and navigate in running Early Access Programmes.

Ahead of this year's conference, Pharma IQ spoke to Arthur Caplan, Head of Bioethics, New York University Langone Medical Center and Chairman, of the Compassionate Use Advisory Committee on the subject of running successful Early Access  Programmes amidst the challenging ethical climate.

Please note: That all fields marked with an asterisk (*) are required.